Trial Profile
Imatinib combined with oncovin and dexamethasone for Ph1 positive ALL, and comparison of two treatment methods after first remission
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Dexamethasone; Vincristine; Vindesine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 05 May 2015 New trial record